Latest revenue growth
Iovance Biotherapeutics Revenue growth
Direct answer
Iovance Biotherapeutics's revenue growth is 65.7%.
The verified market snapshot reports 65.7%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue growth
- 65.7%
Explore related company data
View Iovance Biotherapeutics's market capitalizationView Iovance Biotherapeutics's price-to-book ratioView Iovance Biotherapeutics's return on equityView Iovance Biotherapeutics's dividend yieldView Iovance Biotherapeutics's 52-week price rangeView Iovance Biotherapeutics's profit marginView Iovance Biotherapeutics's debt-to-equity ratioView all Iovance Biotherapeutics key metricsReturn to Iovance Biotherapeutics profile